Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor…
Continue Reading
News Source: medicalxpress.com
GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor…
News Source: medicalxpress.com
Leave a Reply